Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hirohiko Yasui, Yoshinori Imura, Hidetatsu Outani, Ken-ichiro Hamada, Takaaki Nakai, Shutaro Yamada, Satoshi Takenaka, Satoru Sasagawa, Nobuhito Araki, Kazuyuki Itoh, Akira Myoui, Hideki Yoshikawa & Norifumi Naka. (2016) Trabectedin is a promising antitumour agent for synovial sarcoma. Journal of Chemotherapy 28:5, pages 417-424.
Read now
Read now
Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, Domenica Lorusso, Gilda Fuoco, Salvatore Pisconti & Giovanni Scambia. (2010) Pegylated liposomal doxorubicin in the management of ovarian cancer. Therapeutics and Clinical Risk Management 6, pages 463-483.
Read now
Read now
Articles from other publishers (20)
Manmeet Kaur, Mandeep Kaur, Tania Bandopadhyay, Aditi Sharma, Anu Priya, Arvind Singh & Bubun Banerjee. (2023) Naturally occurring, natural product inspired and synthetic heterocyclic anti-cancer drugs. Physical Sciences Reviews 8:10, pages 3393-3446.
Crossref
Crossref
Md. Mizanur Rahaman, Polrat Wilairatana, Mehedi Hasan Bappi, Tawhida Islam, Md. Nayem Mia, Henrique Douglas Melo Coutinho, Abolghasem Siyadatpanah & Muhammad Torequl Islam. (2023) Anticancer effect of herbal and marine products: A systematic review. Journal of King Saud University - Science 35:8, pages 102919.
Crossref
Crossref
Crisalejandra Rivera-Pérez, Xolotl Paloma Ponce González & Norma Yolanda Hernández-Savedra. (2023) Antimicrobial and anticarcinogenic activity of bioactive peptides derived from abalone viscera (Haliotis fulgens and Haliotis corrugata). Scientific Reports 13:1.
Crossref
Crossref
Shashi Kiran Misra & Kamla Pathak. (2023) Naturally occurring heterocyclic anticancer compounds. Physical Sciences Reviews 8:8, pages 1713-1740.
Crossref
Crossref
Zhichao Tian & Weitao Yao. (2023) Chemotherapeutic drugs for soft tissue sarcomas: a review. Frontiers in Pharmacology 14.
Crossref
Crossref
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas & Pradeep Kumar. (2023) Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals 16:2, pages 299.
Crossref
Crossref
Neshatul Haque, Sana Parveen, Tingting Tang, Jiaen Wei & Zunnan Huang. (2022) Marine Natural Products in Clinical Use. Marine Drugs 20:8, pages 528.
Crossref
Crossref
Wessal Hanout & Nir Qvit. 2022. Peptide and Peptidomimetic Therapeutics. Peptide and Peptidomimetic Therapeutics
371
415
.
Kirill I. Kirsanov, Ekaterina A. Lesovaya, Timur I. Fetisov, Beniamin Yu Bokhyan, Gennady A. Belitsky & Marianna G. Yakubovskaya. (2020) Current Approaches for Personalized Therapy of Soft Tissue Sarcomas. Sarcoma 2020, pages 1-15.
Crossref
Crossref
Lan V. Pham, Elizabeth Pogue & Richard J. Ford. (2018) The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas. Frontiers in Oncology 8.
Crossref
Crossref
B Englinger, M Mair, W Miklos, C Pirker, T Mohr, S van Schoonhoven, D Lötsch, W Körner, F Ferk, S Knasmüller, P Heffeter, B K Keppler, M Grusch & W Berger. (2017) Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance. British Journal of Cancer 116:4, pages 489-500.
Crossref
Crossref
Mahiru Kawano, Seiji Mabuchi, Toshiko Kishimoto, Takeshi Hisamatsu, Yuri Matsumoto, Tomoyuki Sasano, Ryoko Takahashi, Kenjiro Sawada, Kazuhiro Takahashi, Toshifumi Takahashi, Toshimitsu Hamasaki & Tadashi Kimura. (2014) Combination Treatment With Trabectedin and Irinotecan or Topotecan Has Synergistic Effects Against Ovarian Clear Cell Carcinoma Cells. International Journal of Gynecologic Cancer 24:5, pages 829-837.
Crossref
Crossref
Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Carla Cavaliere, Rosa Tambaro, Gaetano Facchini, Cono Scaffa, Simona Losito, Antonio Pizzolorusso & Sandro Pignata. (2013) Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer. Journal of Drug Delivery 2013, pages 1-12.
Crossref
Crossref
Yin-Ting Chuang & Chih-Long Chang. (2012) Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance. Taiwanese Journal of Obstetrics and Gynecology 51:3, pages 336-341.
Crossref
Crossref
Bartomeu Massuti, Manuel Cobo, Carlos Camps, Manuel Dómine, Mariano Provencio, Vicente Alberola, Nuria Viñolas, Rafael Rosell, Miguel Tarón, Vanesa Gutiérrez-Calderón, Pilar Lardelli, Vicente Alfaro, Antonio Nieto & Dolores Isla. (2012) Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum. Lung Cancer 76:3, pages 354-361.
Crossref
Crossref
A. Gronchi, B.N. Bui, S. Bonvalot, S. Pilotti, S. Ferrari, P. Hohenberger, R.J. Hohl, G.D. Demetri, A. Le Cesne, P. Lardelli, I. Pérez, A. Nieto, J.C. Tercero, V. Alfaro, E. Tamborini & J.Y. Blay. (2012) Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Annals of Oncology 23:3, pages 771-776.
Crossref
Crossref
Dale G. Nagle & Yu-Dong Zhou. 2012. Handbook of Marine Natural Products. Handbook of Marine Natural Products
1111
1144
.
Seiji Mabuchi, Takeshi Hisamatsu, Chiaki Kawase, Masami Hayashi, Kenjiro Sawada, Kazuya Mimura, Kazuhiro Takahashi, Toshifumi Takahashi, Hirohisa Kurachi & Tadashi Kimura. (2011) The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary. Clinical Cancer Research 17:13, pages 4462-4473.
Crossref
Crossref
S.B. Kaye, N. Colombo, B.J. Monk, S. Tjulandin, B. Kong, M. Roy, S. Chan, E. Filipczyk-Cisarz, H. Hagberg, I. Vergote, C. Lebedinsky, T. Parekh, P. Santabárbara, Y.C. Park, A. Nieto & A. Poveda. (2011) Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval. Annals of Oncology 22:1, pages 49-58.
Crossref
Crossref
E.J.O. Soini, B. García San Andrés & T. Joensuu. (2011) Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information. Annals of Oncology 22:1, pages 215-223.
Crossref
Crossref